Art's Way Manufacturing Co. Inc. FY25 net income from continuing operations hits USD 1.04 million, up more than tenfold

Reuters
02/05
Art's Way Manufacturing Co. Inc. FY25 net income from continuing operations hits USD 1.04 million, up more than tenfold

Art's Way Manufacturing Co. Inc. reported its fiscal year (FY) 2025 results, posting consolidated sales of USD 22.98 million, a 6.2% decrease for the period. Net income from continuing operations reached USD 1.04 million, compared to a net loss in the previous year, with net income per basic and diluted share at USD 0.20. The company's gross profit margin as a percentage of sales declined by 2.5 points, while operating expenses decreased by 12.7% year-on-year. Art's Way Manufacturing received an Employee Retention Credit refund in FY 2025, positively impacting net income from continuing operations by USD 1.05 million. In the Agricultural Products segment, sales were USD 12.75 million, down 13.1% for the year, with a 4.9 point decline in gross profit margin. The company’s Modular Buildings segment contributed to improved profitability and positive net income performance during the period, as highlighted by management. Art's Way Manufacturing continues to operate across two branch locations in Iowa and maintains a focus on both agricultural equipment and modular building solutions.

Disclaimer: This news brief was created by Public Technologies (PUBT) using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. Art's Way Manufacturing Co. Inc. published the original content used to generate this news brief via ACCESS Newswire (Ref. ID: 1133630) on February 04, 2026, and is solely responsible for the information contained therein.

应版权方要求,你需要登录查看该内容

免责声明:投资有风险,本文并非投资建议,以上内容不应被视为任何金融产品的购买或出售要约、建议或邀请,作者或其他用户的任何相关讨论、评论或帖子也不应被视为此类内容。本文仅供一般参考,不考虑您的个人投资目标、财务状况或需求。TTM对信息的准确性和完整性不承担任何责任或保证,投资者应自行研究并在投资前寻求专业建议。

热议股票

  1. 1
     
     
     
     
  2. 2
     
     
     
     
  3. 3
     
     
     
     
  4. 4
     
     
     
     
  5. 5
     
     
     
     
  6. 6
     
     
     
     
  7. 7
     
     
     
     
  8. 8
     
     
     
     
  9. 9
     
     
     
     
  10. 10